Neurana Pharmaceuticals Completes Patient Enrollment in Phase 3 RESUME-1 Study by Seini Moimoi | Nov 29, 2021 | Portfolio News
Lefamulin NDA Filed in Mainland China for Treatment of Community Acquired Pneumonia by Seini Moimoi | Nov 29, 2021 | Portfolio News
Molecular Templates, Inc. Announces Fast Track Designation Granted by FDA for MT-6402 by Seini Moimoi | Nov 18, 2021 | Portfolio News
Axonics® Ranked the Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™ by Seini Moimoi | Nov 17, 2021 | Portfolio News
Tricida Raises $42 Million in Registered Direct Equity Financing by Seini Moimoi | Nov 15, 2021 | Portfolio News
Theseus Pharmaceuticals Announces Business and Program Highlights and Reports Third Quarter 2021 Financial Results by Seini Moimoi | Nov 15, 2021 | Portfolio News
